Thomas Sécher

3.3k total citations · 1 hit paper
50 papers, 2.4k citations indexed

About

Thomas Sécher is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Thomas Sécher has authored 50 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 17 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Thomas Sécher's work include Inhalation and Respiratory Drug Delivery (13 papers), Immune Response and Inflammation (12 papers) and Gut microbiota and health (7 papers). Thomas Sécher is often cited by papers focused on Inhalation and Respiratory Drug Delivery (13 papers), Immune Response and Inflammation (12 papers) and Gut microbiota and health (7 papers). Thomas Sécher collaborates with scholars based in France, Germany and United States. Thomas Sécher's co-authors include Bernhard Ryffel, Éric Oswald, Nathalie Heuzé‐Vourc'h, Jean‐Philippe Nougayrède, Michèle Boury, Mathias Chamaillard, François Erard, Gabriel Núñez, Olivier Gaillot and Sylvain Normand and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Thomas Sécher

47 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer

2013 453 citations Aurélie Couturier-Maillard, Thomas Sécher et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Sécher France	27	1.2k	693	374	290	288	50	2.4k
Jonathan Jantsch Germany	33	847 0.7×	831 1.2×	326 0.9×	223 0.8×	234 0.8×	111	3.3k
Bobby J. Cherayil United States	35	1.1k 1.0×	1.1k 1.5×	440 1.2×	216 0.7×	177 0.6×	70	3.3k
Yimin Yu China	16	992 0.8×	1.2k 1.7×	445 1.2×	235 0.8×	169 0.6×	43	2.6k
Sun‐Young Chang South Korea	26	958 0.8×	899 1.3×	393 1.1×	199 0.7×	100 0.3×	64	2.6k
Kathryn A. Knoop United States	21	1.1k 0.9×	1.0k 1.5×	370 1.0×	345 1.2×	100 0.3×	37	2.6k
Seong Gyu Jeon South Korea	27	1.5k 1.2×	784 1.1×	281 0.8×	167 0.6×	313 1.1×	65	3.2k
Tonyia Eaves‐Pyles United States	20	822 0.7×	506 0.7×	332 0.9×	226 0.8×	154 0.5×	37	1.8k
Aaron Carmody United States	27	794 0.7×	1.1k 1.5×	836 2.2×	237 0.8×	266 0.9×	57	2.9k
Hiroko Nagao‐Kitamoto United States	22	1.3k 1.1×	399 0.6×	357 1.0×	338 1.2×	152 0.5×	27	2.3k

Countries citing papers authored by Thomas Sécher

Since Specialization

Citations

This map shows the geographic impact of Thomas Sécher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Sécher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Sécher more than expected).

Fields of papers citing papers by Thomas Sécher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Sécher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Sécher. The network helps show where Thomas Sécher may publish in the future.

Co-authorship network of co-authors of Thomas Sécher

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Sécher. A scholar is included among the top collaborators of Thomas Sécher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Sécher. Thomas Sécher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sécher, Thomas, et al.. (2024). A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview. Expert Opinion on Drug Delivery. 22(2). 197–218. 1 indexed citations

Sécher, Thomas, Mélanie Cortès, Chloé Boisseau, et al.. (2024). Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa. Molecular Therapy — Methods & Clinical Development. 32(4). 101330–101330. 1 indexed citations

Ferreira, Marion, Christelle Parent, Chloé Boisseau, et al.. (2023). Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection. Mucosal Immunology. 16(3). 312–325. 4 indexed citations

Denevault‐Sabourin, Caroline, Nicolas Joubert, Jean‐Pierre Pouget, et al.. (2021). Therapeutic antibodies – natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics. 233. 108022–108022. 22 indexed citations

Gross, Christelle, et al.. (2020). MAIT Cells Display a Specific Response to Type 1 IFN Underlying the Adjuvant Effect of TLR7/8 Ligands. Frontiers in Immunology. 11. 2097–2097. 15 indexed citations

Sécher, Thomas, Marion Ferreira, Christelle Parent, et al.. (2019). In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration. Journal of Controlled Release. 303. 24–33. 26 indexed citations

Sécher, Thomas, Laurent Guilleminault, Karen L. Reckamp, et al.. (2018). Therapeutic antibodies: A new era in the treatment of respiratory diseases?. Pharmacology & Therapeutics. 189. 149–172. 32 indexed citations

Payros, Delphine, Ulrich Dobrindt, Patricia Martín, et al.. (2017). The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota. mBio. 8(2). 67 indexed citations

Guillon, Antoine, Thomas Sécher, Lea Ann Dailey, et al.. (2017). Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics. International Journal of Pharmaceutics. 536(1). 116–126. 30 indexed citations

10.

Sécher, Thomas, Sahar Kassem, Mehdi Benamar, et al.. (2017). Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction. Frontiers in Immunology. 8. 1096–1096. 109 indexed citations

11.

Nakayama‐Imaohji, Haruyuki, Katsuhiko Hirota, Hisashi Yamasaki, et al.. (2016). DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis. PLoS ONE. 11(2). e0148887–e0148887. 25 indexed citations

12.

Guabiraba, Rodrigo, Anne‐Gaëlle Besnard, Gustavo Batista Menezes, et al.. (2014). IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. Mucosal Immunology. 7(5). 1079–1093. 72 indexed citations

13.

Couturier-Maillard, Aurélie, Thomas Sécher, Ateequr Rehman, et al.. (2013). NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. Journal of Clinical Investigation. 123(2). 700–11. 453 indexed citations breakdown →

14.

Sécher, Thomas, et al.. (2013). The Anti-Pseudomonas aeruginosa Antibody Panobacumab Is Efficacious on Acute Pneumonia in Neutropenic Mice and Has Additive Effects with Meropenem. PLoS ONE. 8(9). e73396–e73396. 36 indexed citations

15.

Sécher, Thomas, Ascel Samba‐Louaka, Éric Oswald, & Jean‐Philippe Nougayrède. (2013). Escherichia coli Producing Colibactin Triggers Premature and Transmissible Senescence in Mammalian Cells. PLoS ONE. 8(10). e77157–e77157. 98 indexed citations

16.

Sécher, Thomas, Louis Fauconnier, Agata Szade, et al.. (2011). Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection. Journal of Antimicrobial Chemotherapy. 66(5). 1100–1109. 42 indexed citations

17.

Couper, Kevin N., Julius Clemence R. Hafalla, Valéry Combes, et al.. (2010). Parasite-Derived Plasma Microparticles Contribute Significantly to Malaria Infection-Induced Inflammation through Potent Macrophage Stimulation. PLoS Pathogens. 6(1). e1000744–e1000744. 185 indexed citations

18.

Victoni, Tatiana, Fernando Rodrigues Coelho, Andressa de Freitas, et al.. (2009). Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Medical Microbiology and Immunology. 199(1). 35–42. 47 indexed citations

19.

Dessein, Rodrigue, Meritxell Gironella, Cécile Vignal, et al.. (2009). Toll-like receptor 2 is critical for induction of Reg3β expression and intestinal clearance of Yersinia pseudotuberculosis. Gut. 58(6). 771–776. 82 indexed citations

20.

Janot, Laure, Thomas Sécher, David Torres, et al.. (2008). CD14 Works with Toll‐Like Receptor 2 to Contribute to Recognition and Control ofListeria monocytogenesInfection. The Journal of Infectious Diseases. 198(1). 115–124. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact